EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Jacareubin Derivatives Increase Their Anti-Allergic Activity

Rosario Tavera-Hernández iD, Jesabel Pérez-Rodríguez iD, Antonio Nieto-Camacho iD, Omar Noel Medina-Campos, José Pedraza-Chaverri iD, Francisco León iD, Claudia González-Espinosa iD, Manuel Jiménez-Estrada iD, Ricardo Reyes-Chilpa, Jorge Ivan Castillo-Arellano iD

Molecules · 15.05.2026 · 31 (10) · 1666

DOI: 10.3390/molecules31101666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 15.05.2026. Verfasst von Rosario Tavera-Hernández und 9 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City 04510, Mexico. Hauptthemen laut MEDLINE: Anti-Allergic Agents, Xanthones. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Nacional Autónoma de México, Ministry of Sciences, Humanities, Technology and Innovation, DGAPA-PAPIIT-UNAM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Jacareubin (2), nujiangexanthone A, and α-mangostin display the highest anti-allergic effects among the active xantones through still not well-known mechanisms. This study investigates the SAR of jacareubin, its precursor xanthone V (1) and their peracetylated (1a and 2a), permethylated (1b and 2b) derivatives and their anti-allergic and anti-inflammatory effects. To characterize the inhibitory effect of jacareubin, 2a and 2b on the anaphylactic reaction, we first utilized in vitro models of bone marrow derived mast cells (BMMCs), determining their capacity of inhibiting the IgE/Antigen-induced degranulation, myeloperoxidase (MPO), and xanthine oxidase (XO) activation. Also, we utilized in vivo models of passive cutaneous anaphylaxis (PCA) and TPA-induced ear edema. In vitro tests showed that the compound 2b was more effective than jacareubin in the inhibition of BMMCs degranulation. Besides, in vivo models of PCA revealed that the fourth cyclized ring of jacareubin is the critical structural element for anti-allergic efficacy, as compound 1 was less effective. Additionally, hydroxyl groups were found to be essential for inhibiting MPO. Jacareubin was the only tested xanthone that directly inhibited XO, a result supported by molecular docking. Overall, jacareubin represents a promising multi-target scaffold that could be used for developing new treatments for inflammatory and allergic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Allergic AgentsXanthonesAnimalsMast CellsMiceMolecular Docking SimulationCell DegranulationPeroxidaseXanthine OxidasePassive Cutaneous AnaphylaxisEdemaStructure-Activity RelationshipAnti-Inflammatory AgentsImmunoglobulin E

Stichwörter der Autor:innen

acetylationanti-allergyanti-inflammatoryjacareubin derivativesmethylationxanthone V

Substanzen

Anti-Allergic AgentsXanthonesPeroxidaseXanthine OxidaseAnti-Inflammatory AgentsImmunoglobulin E

Autor:innen und Institutionen

  • Instituto de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City 04510, Mexico.
  • Posgrado en Producción Animal, Departamento de Zootecnia, Universidad Autónoma Chapingo, Chapingo, Texcoco 56230, Mexico.
  • Facultad de Química, Departamento de Biología, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Departamento de Farmacobiología y Centro de Investigación Sobre el Envejecimiento, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Sede Sur, Tlalpan, Mexico City 14330, Mexico.
  • Laboratorio de Reprogramación Celular, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City 14269, Mexico.

ORCID-Profile: Rosario Tavera-Hernández, Jesabel Pérez-Rodríguez, Antonio Nieto-Camacho, José Pedraza-Chaverri, Francisco León, Claudia González-Espinosa, Manuel Jiménez-Estrada, Jorge Ivan Castillo-Arellano

Förderung

  • Universidad Nacional Autónoma de México
  • Ministry of Sciences, Humanities, Technology and Innovation
  • DGAPA-PAPIIT-UNAM
  • Secihti

Zitieren

APA

Tavera-Hernández, R., Pérez-Rodríguez, J., Nieto-Camacho, A., Medina-Campos, O. N., Pedraza-Chaverri, J., León, F., González-Espinosa, C., Jiménez-Estrada, M., Reyes-Chilpa, R., & Castillo-Arellano, J. I. (2026). Jacareubin Derivatives Increase Their Anti-Allergic Activity. Molecules, 31(10), 1666. https://doi.org/10.3390/molecules31101666

Vancouver

Tavera-Hernández R, Pérez-Rodríguez J, Nieto-Camacho A, Medina-Campos ON, Pedraza-Chaverri J, León F, et al. Jacareubin Derivatives Increase Their Anti-Allergic Activity. Molecules. 2026;31(10):1666. doi:10.3390/molecules31101666

BibTeX
@article{TaveraHernndez2026,
  author = {Tavera-Hernández, Rosario and Pérez-Rodríguez, Jesabel and Nieto-Camacho, Antonio and Medina-Campos, Omar Noel and Pedraza-Chaverri, José and León, Francisco and González-Espinosa, Claudia and Jiménez-Estrada, Manuel and Reyes-Chilpa, Ricardo and Castillo-Arellano, Jorge Ivan},
  title = {Jacareubin Derivatives Increase Their Anti-Allergic Activity},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {10},
  pages = {1666},
  doi = {10.3390/molecules31101666}
}
Kostenlos starten →